Cargando…

Management of advanced prostate cancer in a middle‐income country: real‐world consideration of the Advanced Prostate Cancer Consensus Conference 2017

OBJECTIVE: To examine the results of the Malaysian Advanced Prostate Cancer Consensus Conference (MyAPCCC) 2018, held for assessing the generalizability of consensus reached at the Advanced Prostate Cancer Consensus Conference (APCCC 2017) to Malaysia, a middle‐income country. METHODS: Six key secti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saad, Marniza, Alip, Adlinda, Lim, Jasmine, Abdullah, Matin Mellor, Chong, Flora Li Tze, Chua, Chong Beng, Ismail, Fuad, Khong, Rachael Kit‐Tsan, Lim, Chun Sen, Loh, Chit Sin, Malek, Rohan, Mohd Ghani, Khairul Asri, Md Noor, Ibtisam, Md Yusoff, Noor Ashani, Nasuha, Noor Azam, Razack, Azad, Soo Hoo, Hwoei Fen, Sundram, Murali, Tan, Hui Meng, Thiagarajan, Muthukkumaran, Teh, Guan Chou, Voon, Pei Jye, Ong, Teng Aik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851975/ https://www.ncbi.nlm.nih.gov/pubmed/31077523 http://dx.doi.org/10.1111/bju.14807

Ejemplares similares

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
por: Lim, Jasmine, et al.
Publicado: (2020)

Novel hormonal therapies in the management of advanced prostate cancer: extrapolating Asian findings to Southeast Asia
por: Ong, Teng Aik, et al.
Publicado: (2023)

Single vs multiple fraction palliative radiotherapy for uncomplicated painful bone metastases treated at University of Malaya Medical Centre: A single institutional Malaysian experience
por: Duraisamy, Ina Shaliny, et al.
Publicado: (2018)

Modified J‐CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy
por: Lim, Jasmine, et al.
Publicado: (2020)

United in Fight against prOstate cancer (UFO) registry: first results from a large, multi‐centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
por: Uemura, Hirotsugu, et al.
Publicado: (2020)

Prostate cancer in multi‐ethnic Asian men: Real‐world experience in the Malaysia Prostate Cancer (M‐CaP) Study
por: Lim, Jasmine, et al.
Publicado: (2021)

Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high‐ and middle‐income Asian countries
por: Lim, Jasmine, et al.
Publicado: (2021)

Cardiovascular risk factors, ethnicity and infection stone are independent factors associated with reduced renal function in renal stone formers
por: Choy, Seow Huey, et al.
Publicado: (2022)

Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
por: Saad, Marniza, et al.
Publicado: (2022)

Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements
por: Chiong, Edmund, et al.
Publicado: (2022)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

To Share or Not to Share: Malaysian Healthcare Professionals' Views on Localized Prostate Cancer Treatment Decision Making Roles
por: Lee, Yew Kong, et al.
Publicado: (2015)

Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country
por: How, Soon Hin, et al.
Publicado: (2022)

Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems
por: Leu, Jassica S. L., et al.
Publicado: (2023)

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study
por: Ho, Gwo-Fuang, et al.
Publicado: (2019)

Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia
por: How, Soon Hin, et al.
Publicado: (2022)

Advancements and Applications of Liquid Biopsies in Oncology: A Narrative Review
por: Noor, Jawad, et al.
Publicado: (2023)

A bibliometric and content analysis of technological advancement applications in agricultural e-commerce
por: Altarturi, Hamza H. M., et al.
Publicado: (2023)

Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma
por: Mannatrizio, Domenico, et al.
Publicado: (2023)

BRCA2 gene mutation and prostate cancer risk: Comprehensive review and update
por: Junejo, Noor N., et al.
Publicado: (2020)

Advances in prostate cancer imaging
por: Tangel, Matthew R., et al.
Publicado: (2018)

Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting
por: Lim, Jasmine, et al.
Publicado: (2014)

Cardiovascular Risk Factors and Ethnicity Are Independent Factors Associated with Lower Urinary Tract Symptoms
por: Lim, Jasmine, et al.
Publicado: (2015)

Prostate adenocarcinoma presenting as diffuse osteolytic metastasis
por: Faisal, Mohanad, et al.
Publicado: (2022)

A Rare Case of Steroid Cell Tumor, Not Otherwise Specified (NOS), of the Ovary in a Young Woman
por: Tan, Eek Chaw, et al.
Publicado: (2019)

Advancements in Diagnostic and Therapeutic Interventions of Non-alcoholic Fatty Liver Disease: A Literature Review
por: Chaudhry, Ahtshamullah, et al.
Publicado: (2023)

New developments in the use of prostatic stents
por: Papatsoris, Athanasios G, et al.
Publicado: (2011)

Advances in prostate cancer research models: From transgenic mice to tumor xenografting models
por: Huang, Yuejiao, et al.
Publicado: (2016)

Trends and Advances in Electrochemiluminescence Nanobiosensors
por: Rizwan, Mohammad, et al.
Publicado: (2018)

Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
por: Chai, Chee-Shee, et al.
Publicado: (2020)

Preparing for and conducting the National Health and Morbidity Survey in Malaysia amid the COVID-19 pandemic: balancing risks and benefits to participants and society
por: Chong, Zhuo Lin, et al.
Publicado: (2021)

Controversies in the management of advanced prostate cancer
por: Tyrrell, C J
Publicado: (1999)

Weekly chemotherapy in advanced prostatic cancer.
por: Francini, G., et al.
Publicado: (1993)

Sipuleucel-T: immunotherapy for advanced prostate cancer
por: Olson, Brian M, et al.
Publicado: (2011)

Advances in Prostate Cancer Research and Treatment
por: Livi, Lorenzo, et al.
Publicado: (2014)

Advances in Radiotherapy for Prostate Cancer Treatment
por: Podder, Tarun, et al.
Publicado: (2016)

Advances in Localized Prostate Cancer Management
por: Samadi, David B., et al.
Publicado: (2018)

Multimodal treatments for advanced prostate cancer
por: Faiena, Izak, et al.
Publicado: (2019)

CD38 in Advanced Prostate Cancers
por: Guo, Christina, et al.
Publicado: (2021)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ks4ugpf02snm2bqtvthg85eun